NO942456L - Fremgangsmåte for fremstilling av trombin - Google Patents

Fremgangsmåte for fremstilling av trombin

Info

Publication number
NO942456L
NO942456L NO942456A NO942456A NO942456L NO 942456 L NO942456 L NO 942456L NO 942456 A NO942456 A NO 942456A NO 942456 A NO942456 A NO 942456A NO 942456 L NO942456 L NO 942456L
Authority
NO
Norway
Prior art keywords
thrombin
host cells
produced
transfected
transformed
Prior art date
Application number
NO942456A
Other languages
English (en)
Other versions
NO317018B1 (no
NO942456D0 (no
Inventor
Richard D Holly
Donald Cameron Foster
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO942456L publication Critical patent/NO942456L/no
Publication of NO942456D0 publication Critical patent/NO942456D0/no
Publication of NO317018B1 publication Critical patent/NO317018B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO19942456A 1991-12-31 1994-06-29 DNA konstruksjon, vertcelle, fremgangsmater for fremstilling av Trombin, farmasoytisk sammensettning samt anvendelser derav NO317018B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81628191A 1991-12-31 1991-12-31
US86070192A 1992-03-31 1992-03-31
PCT/US1992/011357 WO1993013208A1 (en) 1991-12-31 1992-12-30 Methods for producing thrombin

Publications (3)

Publication Number Publication Date
NO942456L true NO942456L (no) 1994-06-29
NO942456D0 NO942456D0 (no) 1994-06-29
NO317018B1 NO317018B1 (no) 2004-07-26

Family

ID=27124054

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19942456A NO317018B1 (no) 1991-12-31 1994-06-29 DNA konstruksjon, vertcelle, fremgangsmater for fremstilling av Trombin, farmasoytisk sammensettning samt anvendelser derav

Country Status (13)

Country Link
US (2) US5476777A (no)
EP (1) EP0624199B1 (no)
JP (1) JP3404038B2 (no)
AT (1) ATE179754T1 (no)
AU (1) AU683834B2 (no)
CA (1) CA2125783C (no)
DE (1) DE69229126T2 (no)
DK (1) DK0624199T3 (no)
ES (1) ES2134836T3 (no)
FI (1) FI117831B (no)
GR (1) GR3030820T3 (no)
NO (1) NO317018B1 (no)
WO (1) WO1993013208A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010322A1 (en) * 1992-10-29 1994-05-11 Board Of Regents, The University Of Texas System Adenovirus-mediated ldl receptor gene transfer and targeting
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
EP0993311B1 (en) * 1997-06-18 2012-11-14 Angiotech Pharmaceuticals (US), Inc. Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof
US20030207402A1 (en) * 1997-08-22 2003-11-06 Erhard Kopetzki Autocatalytically activatable zymogenic precursors of proteases and their use
JP2002506038A (ja) * 1998-03-10 2002-02-26 バクスター・インターナショナル・インコーポレイテッド トロンビン調製およびトロンビン産物ならびにそれを使用するフィブリンシーラント方法
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors
US20030096771A1 (en) * 2001-07-26 2003-05-22 Butler Madeline M. Antisense modulation of hormone-sensitive lipase expression
KR20000018933A (ko) * 1998-09-07 2000-04-06 김승수 내피세포 성장억제 활성을 가지는 사람 프로트롬빈 크링글단백질 및 이를 암호하는 유전자
IL129427A0 (en) * 1999-04-13 2000-02-17 Yeda Res & Dev Preparation of biologically active molecules
WO2001011952A1 (en) * 1999-08-19 2001-02-22 Us Transgenics, Inc. Transgenic prothrombin and related thrombin precursors and transgenics, methods, compositions, uses and the like relating thereto
JP2005506832A (ja) * 2001-05-14 2005-03-10 デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー トランスメンブランセリンプロテアーゼ１０をコードする核酸分子、コードされるポリペプチドおよびそれに基づく方法
US7772459B2 (en) 2002-02-20 2010-08-10 Bellweather Farms Transgenic production in saliva
US20100254900A1 (en) * 2002-03-18 2010-10-07 Campbell Phil G Biocompatible polymers and Methods of use
US8293530B2 (en) * 2006-10-17 2012-10-23 Carnegie Mellon University Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
WO2003079985A2 (en) * 2002-03-18 2003-10-02 Carnegie Mellon University Method and apparatus for preparing biomimetic scaffold
US8529956B2 (en) 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
US20060270014A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
US7825231B2 (en) * 2005-06-01 2010-11-02 Darren P. Wolfe Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
EP2093256A3 (en) 2005-07-28 2009-10-14 Carnegie Mellon University Biocompatible polymers and methods of use
US20090137001A1 (en) 2005-09-30 2009-05-28 Tatsufumi Onchi Process for preparing recombinant human thrombin with culture cell
JP2009528843A (ja) * 2006-03-06 2009-08-13 ヒューマジーン・インコーポレイテッド 組換えヒトトロンビンおよびフィブリノゲンの調製法
US8529958B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US20100062981A1 (en) * 2007-01-31 2010-03-11 Anders Jeppsson Use of fibrinogen as a prophylactic treatment to prevent bleeding during and after surgery and as a biomarker to identify patient with an increased risk for excessive bleeding and blood transfusion
WO2009032966A1 (en) * 2007-09-05 2009-03-12 Zymogenetics, Inc. Mass spectrometry-based quantitative assay for determining abundance of molecular species in a composition
AU2009240441B2 (en) * 2008-04-25 2014-08-21 Baxter International Inc. Medical devices for delivering fluids during surgery and methods for their use
WO2014115087A2 (en) 2013-01-22 2014-07-31 Cencor Biotech Ltd. A method for the preparation of recombinant human prothrombin and fibrinogen
WO2020229521A1 (en) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for inhibiting or reducing bacterial biofilms on a surface

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910005081B1 (ko) * 1988-09-23 1991-07-22 삼성전관 주식회사 칼라브라운관의 형광면 제작방법
ES2052368T3 (es) * 1990-01-26 1994-07-01 Immuno Ag Factores sanguineos producidos por recombinacion y el proceso para la expresion de dichos factores, asi como recombinacion del virus de vaccina usados en dicho proceso.
EP0443724B1 (en) * 1990-02-20 1999-03-17 Baxter International Inc. Viral-safe purified human thrombin

Also Published As

Publication number Publication date
FI943122L (fi) 1994-06-29
EP0624199B1 (en) 1999-05-06
ES2134836T3 (es) 1999-10-16
JPH07502659A (ja) 1995-03-23
AU683834B2 (en) 1997-11-27
EP0624199A1 (en) 1994-11-17
US5476777A (en) 1995-12-19
NO317018B1 (no) 2004-07-26
FI117831B (fi) 2007-03-15
ATE179754T1 (de) 1999-05-15
DE69229126D1 (de) 1999-06-10
WO1993013208A1 (en) 1993-07-08
AU3428793A (en) 1993-07-28
NO942456D0 (no) 1994-06-29
US5502034A (en) 1996-03-26
JP3404038B2 (ja) 2003-05-06
GR3030820T3 (en) 1999-11-30
FI943122A0 (fi) 1994-06-29
DE69229126T2 (de) 1999-12-30
CA2125783A1 (en) 1993-07-08
CA2125783C (en) 2003-03-25
DK0624199T3 (da) 1999-11-01

Similar Documents

Publication Publication Date Title
NO942456D0 (no) Fremgangsmåte for fremstilling av trombin
AU6801487A (en) Method of producing a recombinant protein complex having human factor VIII:C activity
DE69434408D1 (de) Recombinante Herstellung aromatischer Polyketiden
NO874495L (no) Ekspresjon av protein c.
HUT43634A (en) Process for expressing vii and ix factor-activity in mammalian celles
ES2000178A6 (es) Procedimiento para producir una secuencia de polipeptidos y metodo para purificar una sustancia.
DK0830376T3 (da) Fremgangsmåde til fremstilling af erythropoietin, som er fri for animalske proteiner
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
NO862601D0 (no) Ekspresjon av protein c.
EP0182448A3 (en) Production of factor viii and related products
NL960017I1 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
WO1992013078A3 (en) Pasteurella haemolytica glycoprotease gene and the purified enzyme
DK0749489T3 (da) Ekspressionskassette, der omfatter en promotor stammende fra pho4-genet fra Schizosaccharomyces pombe
HUP9701904A2 (hu) D-panolakton hidroláz és az azt kódoló gén
ES8707565A1 (es) Un procedimiento para producir un anticuerpo monoclonal
NO307612B1 (no) Fremgangsmåte for fremstilling av en vevstypeplasminogen- aktivatorvariant
DE3850456D1 (de) Klonierung des isoamylaseenzym kodierenden Gens und seine Verwendung zur Herstellung dieses Enzyms.
ATE112319T1 (de) Klonierungs- und/oder expressionsvektoren, verfahren zur ihrer herstellung und verwendung.
PT87424A (pt) Expression of foreign genes in drosophila cells
KR910014508A (ko) 사람인슈린 단백질을 생산하는 담배 및 그의 제조방법
KR900018378A (ko) 사람 프로우로키나제 변이체, 이를 제조하는 방법, 이에 대한 dna 서열, 플라스미드 및 숙주
PT86744A (pt) Vectores de expressao retroviral e metodos para produzir antigenios de vhb

Legal Events

Date Code Title Description
MK1K Patent expired